Potent, ATP-competitive inhibitor of Clk-family kinases (IC50
values are 15, 20 and 200 nM for mClk4, 1 and 2 respectively and >10 μ
M for mClk3). Also inhibits DYRK1A/B (IC50
values are 24 and 34 nM respectively). Suppresses serine/arginine-rich protein phosphorylation; affects the regulation of alternative splicing by phosphorylation of SR protein both in vitro
and in vivo
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II.
Foucourt et al.
Manipulation of alternative splicing by a newly developed inhibitor of Clks.
Muraki et al.